und die Wirksamkeit liegt ganz offensichtlich nicht an dem Artemisinin.
Es könnte eine Alternative zur Impfung sein:
If subsequent clinical trials are successful, A. annua could potentially serve as a safe therapeutic that could be provided globally at reasonable cost and offer an alternative to vaccines.
The UK and South African variants, B1.1.7 and B1.351, were similarly inhibited.